Search for: "Pharmacia " Results 101 - 120 of 173
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Feb 2014, 3:18 pm by Ronald V. Miller, Jr.
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Testosterone is a 19-carbon steroid hormone. [read post]
1 Mar 2010, 12:22 am by Dr. Shezad Malik
Until 1995, many patients combined Premarin, Wyeth's estrogen-based drug, with progestin-laden Provera, made by Pfizer's Pharmacia & Upjohn unit. [read post]
18 Feb 2014, 3:18 pm by Ronald V. Miller, Jr.
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Testosterone is a 19-carbon steroid hormone. [read post]
20 May 2010, 7:30 am by Stephen Albainy-Jenei
The judge followed the Court of Justice’s interpretation of Article 3(d) in Pharmacia, MIT and Yissum, holding that the authorization required under 3(b) is the first authorisation to place the product on the market as “any” medicinal product. [read post]
18 Feb 2014, 3:18 pm by Ronald V. Miller, Jr.
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Testosterone is a 19-carbon steroid hormone. [read post]
16 Apr 2014, 5:35 am by Ronald V. Miller, Jr.
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Researchers have long suspected a link between testosterone treatment and the risk of heart attack, though millions of men who have been taking the hormonal treatments are just now learning of the… [read post]
17 Apr 2012, 4:30 am
., Pharmacia Corp., and Pfizer, Inc., in the Circuit Court of St. [read post]
25 Jan 2017, 11:25 pm
He notes that the Neurim decision seems to be inconsistent with the CJEU’s decisions in MIT, GSK, Pharmacia and Yissum. [read post]
23 Dec 2018, 4:01 am
The AG refers to CJEU case-law in Yissum and Pharmacia Italia, providing that the definition of the term “product” is independent of the therapeutic use concerned, meaning that an active ingredient or a “combination of active ingredients” remains the same product irrespective of the different therapeutic uses this might have. [read post]
8 Jun 2013, 10:35 am by Madhulika Vishwanathan
Sugen’s appeal against the revocation was fixed for hearing on May 14th 2013 subject to the undertaking given by the appellant (Sugen) that they will not use the revoked patent against the second respondent (Cipla) in other proceedings.According to the appellant (Sugen/Pharmacia) the opposition was not sustainable (second revocation decision) due to the following grounds, which are detailed below:Consideration of Section 25(2) (b):Sugen argued that Section 25(2) (b) should have not… [read post]
7 May 2013, 8:53 am
I do not detect anything in the decisions of the Court of Appeal in Pharmacia and Unilin Beheer which is inconsistent with this approach and in my judgment is one which this court should adopt. [read post]
19 Dec 2013, 4:56 pm
(Enlarged Board of Appeal in G2/98).Priority can be lost by:narrowing down the disclosure from the priority document in a manner which the invention could not be derived directly and unambiguously from it (Pharmacia Corp v Merck & Co Inc [2002] RPC 41); orwidening or generalizing from the priority disclosure (Beloit Technologies Inc and another v Valmet Paper Machinery Inc and another [1995] RPC 7005 and Unilin)The story continues in Part II. [read post]
23 Jan 2020, 12:55 pm by Alexa von Uexküll
The Neurim decision is highly controversial, as it is in conflict with the literal wording of the provisions of the SPC Regulation, as well as the previous standing case law, as evidenced by Pharmacia (C-31/03), Yissum (C-202/05) and MIT (C-431/04). [read post]
5 Jan 2010, 5:37 am by John J. Cord
Plaintiff was on hormone therapy, including Provera (manufactured by Pharmacia & Upjohn, owned by Pfizer) for ten years, through three different physicians. [read post]
22 Jul 2014, 10:17 am by Ronald V. Miller, Jr.
 While AndroGel (Abbvie/Abbott) is one of the most popular of these treatments, they also include: Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/Glaxo) Testopel (Auxilium) The gist of it is that low testosterone treatments may double the risk of heart attack for young men with heart disease as well as for men 65 years of age and older,… [read post]
22 Jan 2010, 12:03 am by Dr. Shezad Malik
"Under the totality of circumstances, which included the facts that none of her prescribing physicians told her there was a causal link between her HRT and breast cancer, and the product information for Provera [a progesterone hormonal substitute manufactured by Pharmacia & Upjohn Co., now owned by Pfizer] was entirely dismissive of any such connection ... it defies logic, contrary to the trial court's suggestion, that appellant [Simon] should have been aware of the risk of… [read post]